Illumina, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the third quarter of 2013.

Third quarter 2013 results:

• Revenue of $357 million, a 25% increase compared to $286 million in the third quarter of 2012

• GAAP net income for the quarter of $31 million, or $0.22 per diluted share, compared to $30 million, or $0.22 per diluted share, for the third quarter of 2012

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC